The use of propolis as vaccine's adjuvant

Vaccine

Volumn 31, Issue 1, 2012, Pages 31-39

  El Ashry, El Sayed H ^a   Ahmad, Tarek A ^b  

^a Alexandria University Faculty Of Science   (Egypt)

^b BIBLIOTHECA ALEXANDRINA   (Egypt)

Author keywords

Adjuvants; Immunopotentiators; Natural products; Propolis; Vaccines

Indexed keywords

AEROMONAS HYDROPHILA VACCINE; ASTRAGALUS POLYSACCHARIDE; BACTERIAL VACCINE; BACTERIUM ANTIBODY; CHINESE ANGELICA POLYSACCHARIDE; CHOLERA VACCINE; ENTEROTOXIGENIC ESCHERICHIA COLI ANTIBODY F4; EPIMEDIUM FLAVONE; EPIMEDIUM POLYSACCHARIDE; FREUND ADJUVANT; GAMMA INTERFERON; HEPATITIS A VACCINE; HERBACEOUS AGENT; HERPES SIMPLEX VACCINE; HERPES VACCINE; IMMUNOGLOBULIN A; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 6; ISATIS ROOT POLYSACCHARIDE; NEWCASTLE DISEASE VACCINE; POLYSACCHARIDE; PROPOLIS; PROPOLIS FLAVONE; PROPOLIS POLYSACCHARIDE; TOXOPLASMA GONDII VACCINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRUS VACCINE;

AEROMONAS HYDROPHILA; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; CHEMICAL COMPOSITION; CHINESE MEDICINE; DERMATITIS; DIARRHEA; DRUG POTENCY; DRUG SAFETY; EMULSION; ENTEROTOXIGENIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; HEPATITIS A; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; KLEBSIELLA PNEUMONIAE INFECTION; LEUKOCYTE; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MORTALITY; MUCOSAL IMMUNITY; NEWCASTLE DISEASE; NONHUMAN; PASTEURELLA MULTOCIDA INFECTION; PORCINE PARVOVIRUS; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; TOXOPLASMA GONDII; TOXOPLASMOSIS; ULCER; WOUND HEALING;

EID: 84975886581     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.10.095     Document Type: Review

References (142)

1. Aguilar J.C., Rodriguez E.G. Vaccine adjuvants revisited. Vaccine 2007, 25:3752-3762.
2. Kamal H. The book of ancient Egyptian medicine 1991, Madbouly Books Store, Cairo.
3. Retief F., Cilliers L. Measles in antiquity and the middle ages. S Afr Med J 2010, 100:216-217.
4. Lombard M., Pastoret P.P., Moulin A.M. A brief history of vaccines and vaccination. Rev Sci Tech Off Int Epiz 2007, 26:29-48.
5. Lund O., Strunge N.M., Lundegaard C. Immunological bioinformatics 2005, MIT Press, Masachetsutes.
6. Henricy A (editor). Lady Mary Wortley Montagu, Letters of the Right Honourable Lady Mary Wortley Montagu: Written During her Travels in Europe, Asia and Africa; 1796.
7. Hopkins D.R. The greatest killer: smallpox in history with a new introduction 2002, University of Chicago Press, Chicago.
8. Vogel F.R. Adjuvants in perspective. Modulation of the immune response to vaccine antigens. Dev. Biol. Stand. 1998, 241-248. Bael, Karger. F. Brown, L.R. Haaheim (Eds.).
9. Ramon G. Sur l'augmentation anormale de l'antitoxine chez les chevaux producteurs de serum antidiphterique. Bull Soc Centr Med Vet 1925, 101:227-234.
10. Ramon G. Procedes pour accroitre la production des antitoxins. Ann Inst Pasteur 1926, 40:1-10.
11. Lima K.M., dos Santos S.A., Rodrigues J.M., Silva C.L. Vaccine adjuvant: it makes the difference. Vaccine 2004, 22:2374-2379.
12. Marciani D.J. Vaccine adjuvants: role and mechanism of action in vaccine immunogenicity. Drug Discov Today 2003, 8:934-943.
13. Edelman R. Vaccine adjuvants. Rev Infect Dis 1980, 2:370-383.
14. Edelman R. An update on vaccine adjuvants in clinical trials. AIDS Res Hum Retroviruses 1992, 8:1409-1411.
15. Allison A.C., Byars N.E. Immunological adjuvants: desirable properties and side-effects. Mol Immunol 1991, 28:279-284.
16. Goldenthal K.L., Cavagnaro J.A., Alving C.R., Vogel F.R., National Cooperative Vaccine Development Working Group Safety evaluation of vaccine adjuvants. AIDS Res Hum Retroviruses 1993, 9:S45-S49.
17. Byars N.E., Allison A.C. Immunologic adjuvants: general properties, advantages and limitations. Laboratory methods in immunology 1990, 39-51. CRC Press, Boca Raton. H. Zola (Ed.).
18. Jennings R., Simms J.R., Heath A.W. Adjuvants and delivery systems for viral vaccines-mechanisms and potential. Modulation of the immune response to vaccine antigens. Dev Biol Stand 1998, 19-28. Karger, Basel. F. Brown, L.R. Haaheim (Eds.).
19. Petrovsky N., Aguilar J.C. Vaccine adjuvants: current state and future trends. Immunol Cell Biol 2004, 82:488-496.
20. Lindblad E.B. Aluminium adjuvants. The theory and practical application of adjuvants 1995, 21-35. JohnWiley & Sons Ltd. D.E.S. Stewart-Tull (Ed.).
21. Heinrich M., Modarai M., Kortenkamp A. Herbal extracts used for upper respiratory tract infections: are there clinically relevant interactions with the cytochrome P450 enzyme system?. Planta Med 2008, 74:657-660.
22. Castaldo S., Capasso F. Propolis, an old remedy used in modern medicine. Fitoterapia 2002, 73:S1-S6.
23. Hegazi A.G., Abd El Hady F.K. Chemical and biological studies of Egyptian propolis. International Symposium On Apitherapy 1997.
24. Hegazi A.G., Abd El Hady F.K., El Menway F.A., Al Mehdar H. Egyptian propolis: 5 influence of propolis adminestration on some chicken biochemical parameters. J Vet Sci Technol 2004, 1:43-58.
25. Ghisalberti E.L. Propolis: a review. Bee World 1979, 60:59-84.
26. Bankova V. Chemical diversity of propolis and the problem of standardization. J Ethnopharmacol 2005, 100:114-117.
27. Sforcin J.M. Propolis and the immune system: a review. J Ethnopharmacol 2007, 113:1-14.
28. Sforcin J.M., Bankova V. Propolis: is there a potential for the development of new drugs?. J Ethnopharmacol 2011, 133:253-260.
29. Burdock G.A. Review of the biological properties and toxicity of bee propolis (propolis). Food Chem Toxicol 1998, 36:347-363.
30. Salatino A., Teixeira E.W., Negri G., Message D. Origin and chemical variation of Brazilian propolis. Evid Based Complement Alternat Med 2005, 2:33-38.
31. Kaneeda J., Nishina T. Safetiness of propolis. Acute toxicity. Honeybee Sci 1994, 15:29-33.
32. Sforcin J.M., Novelli E.L.B., Funari S.R.C. Seasonal effect of Brazilian propolis on seric biochemical variables. J Venom Anim Toxins 2002, 8:244-254.
33. Sforcin J.M., Funari S.R.C., Novelli E.L.B. Serum biochemical determinations of propolis-treated rats. J Venom Anim Toxins 1995, 1:31-37.
34. Jasprica I., Mornar A., Debeljak Z., Smolcic-Bubalo A., Medic-Saric M., Mayer L., et al. In vivo study of propolis supplementation effects on antioxidative status and red blood cells. J Ethnopharmacol 2007, 110:548-554.
35. Mani F., Damasceno H.C.R., Novelli E.L.B., Martins E.A.M., Sforcin J.M., Propolis: effect of different concentrations, extracts and intake period on seric biochemical variables. J Ethnopharmacol 2006, 105:95-98.
36. Cuesta A., Rodri{dotless}guez A., Esteban M.A., Meseguer J. In vivo effects of propolis, a honeybee product, on gilthead seabream innate immune responses. Fish Shelfish Immunol 2005, 18:71-80.
37. Callejo A., Armentia A., Lombardero M., Asensio T. Propolis, a new bee-related allergen. Allergy 2001, 56:579.
38. Hegyi E., Suchy V., Nagy M. Propolis allergy. Hautartz 1990, 41:675-679.
39. Hausen B.M., Wollenweber E., Senff H., Post B. Propolis allergy. (II). The sensitizing properties of 1,1-dimethylallyl caffeic acid ester. Contact Dermatitis 1987, 17:171-177.
40. Silvani S., Spettoli E., Stacul F., Tosti A. Contact dermatitis in psoriasis due to propolis. Contact Dermatitis 1997, 37:48-57.
41. Talas Z.S., Gulhan M.F. Effects of various propolis concentrations on biochemical and hematological parameters of rainbow trout (Oncorhynchus mykiss). Ecotoxicol Environ Saf 2009, 72:1994-1998.
42. Badawi AM. Some biochemical effects of the propolis under the normal conditions in rats. M.Sc., Cairo University, Giza, Egypt; 1990.
43. Eraslan G., Kanbur M., Silici S. Evaluation of propolis effects on some biochemical parameters in rats treated with sodium fluoride. Pestic Biochem Physiol 2007, 88:273-283.
44. Kleinrok Z., Borzecki Z., Scheller S., Matuga W. Biological properties and clinical application of propolis X. Preliminary pharmacological evaluation of ethanol extract of propolis (EEP). Arzneimittelforschung 1978, 28:291-292.
45. Oliveira T.T., Nagem T.J., Ribeiro J.N. Serum activities of aspartate aminotransferase, alanine aminotransferase and gamma glutamyl transpeptidase enzymes in rabbits treated with crude extract of propolis. Rev Cienc Farm Basica Apl 2005, 26:25-28.
46. Chu W.H. Adjuvant effect of propolis on immunization by inactivated Aeromonas hydrophila in carp (Carassrus auratus gibelio). Fish Shellfish Immunol 2006, 21:113-117.
47. Onlen Y., Tamer C., Oksuz H., Duran N., Altug M.E., Yakan S. Comparative trial of different anti-bacterial combinations with propolis and ciprofloxacin on Pseudomonas keratitis in rabbits. Microbiol Res 2007, 162:62-68.
48. Janes K., Bumba V. Composition of bee glue (propolis). Pharmazie 1974, 29:544-545. [German].
49. Chanyshev Z.G., Kudashev A.K. Chemical composition of propolis. Veterinariia 1976, 8:100. [Russian].
50. Nikolaev AB. Defending the bee town. In Remarkable hive product: Propolis. Scientific data and suggestions concerning its composition, properties and possible use in therapeutics. APIMONDIA Standing Commission on Beekeeping Technology and Equipment 1978; Bucharest.
51. Khayyal M.T., El-Ghazaly M.A., El-Khatib A.S. Mechanisms involved in the antiinflamatory effect of propolis extract. Drugs Exp Res 1993, 19:197-203.
52. Moreira T.F. Chemical composition of propolis: vitamins and amino acids. Rev Bras Farmacogn 1986, 1:12-19.
53. Greenaway W., Scasbroock T., Whatley F.R. The composition and plant origins of propolis: a report of work at Oxford. Bee World 1990, 71:107-118.
54. Popova M., Trusheva B., Cutajar S., Antonova D., Mifsud D., Farrugia C., et al. Identification of the plant origin of the botanical biomarkers of Mediterranean type propolis. Nat Prod Commun 2012, 7:569-570.
55. Popova M.P., Bankova V.S., Bogdanov S.B., Tsvetkova I., Naydenski C.N., Marcazzan G.L., et al. Chemical characteristics of poplar type propolis of different geographic origin. Apidologie 2007, 38:306-311.
56. Velikova M., Bankova V., Sorkun K., Houcine S., Tsvetkova I., Kujumgiev A. Propolis from the Mediterranean region: chemical composition and antimicrobial activity. Z Naturforsch C 2000, 55:790-793.
57. Sahinler N., Kaftanoglu O. Natural product propolis: chemical composition. Nat Prod Res 2005, 19:183-188.
58. Bankova V., Popova M., Bogdanov S., Sabatini A.G. Chemical composition of European propolis: expected and unexpected results. Z Naturforsch C 2002, 57:530-533.
59. Majiene D., Trumbeckaite S., Grūnoviene D., Ivanauskas L., Gendrolis A. Investigation of chemical composition of propolis extract. Medicina (Kaunas) 2004, 40:771-774. [Lithuanian].
60. Kumazawa S., Hayashi K., Kajiya K., Ishii T., Hamasaka T., Nakayama T. Studies on the constituents of Uruguayan propolis. J Agric Food Chem 2002, 50:4777-4782.
61. Isla M.I., Paredes-Guzman J.F., Nieva-Moreno M.I., Koo H., Park Y.K. Some chemical composition and biological activity of northern Argentine propolis. J Agric Food Chem 2005, 53:1166-1172.
62. Alencar S.M., Oldoni T.L., Castro M.L., Cabral I.S., Costa-Neto C.M., Cury J.A., et al. Chemical composition and biological activity of a new type of Brazilian propolis: red propolis. J Ethnopharmacol 2007, 113:278-283.
63. Nunes C.A., Guerreiro M.C. Characterization of Brazilian green propolis throughout the seasons by headspace GC/MS and ESI-MS. J Sci Food Agric 2012, 92:433-438.
64. Wu P., Ye L. Determination of effective components in propolis. Wei Sheng Yan Jiu 2000, 29:123-124. [Chinese].
65. Nagy E., Papay V., Litkei G., Dinya Z. Investigation of the chemical constitutents. Particularly the flavonoid components, of propolis and populi gemma by the GC/MS method. Stud Org Chem - Flavonoids Bioflavonoids 1985, 23:223-232.
66. Abd El-Hady F.K. Gas chromatography-mass spectrometry (GC/MS) study of the Egyptian propolis-2-flavonoid constituents. Egypt J Appl Sci 1994, 9:91-109.
67. Abd El-Hady F.K., Hegazi A.G. Gas chromatography-mass spectrometry (GC/MS) study of the Egyptian propolis 1-aliphatic, phenolic acids and their esters. Egypt J Appl Sci 1994, 9:749-760.
68. Zhao H., Zhao K., Yu Y., Li G., Ma J., Zhang H. Preparation and application of propolis inactivated vaccine of Haemophilus parasuis. Shengwu Jishu 2009, 19:72-74. [Chinese].
69. Meng J., Li L., Ge L., Li X., Ye X. Studies on adjuvanticity of HOU-C14 to newcastle disease vaccine (Clone30) of chickens. Zhongguo Shouyi Zazhi 2009, 45:6-8. [Chinese].
70. Jin T., Gu Y., Ma W., Zhou S., Li F., Guo L., et al. Preparation of triple inactivated vaccine comprising avian Pasteurella multocida, Escherichia coli, Klebsiella and propolis. Heilongjiang Xumu Shouyi 2009, 99-100. [Chinese].
71. Cai J.L., Tang X.L., Yang L.F., Su X.Y. Propolis inactivated vaccine against infectious Serositis in young ducks. Chin J Vet Sci 2001, 2001-2006. [Chinese].
72. Wang Y., Wang Y., Cui S., Wang C. Bivalent proplis-adjuvant inactivated vaccine against rabbit colibacillosis. Chin J Prev Vet Med 2000, 2000-2005. [Chinese].
73. Liu Y.Z., Yang J.T., Cai Y. Application of immune adjuvants in preparing inactivated vaccine against Haemolytica mannheimia. J Trad Chin Vet Med 2008, 27:38-40. [Chinese].
74. Teterev I.I. Adjuvant effect of bee glue in vaccine against parathyphoid in calves. Veterinariia 1969, 46:28-29. [Russian].
75. Zhiqiang S. Bee glue vaccine of poultry cholera and its preparation method. Faming Zhuanli Shenqing Gongkai Shuomingshu 1991; CN 1052330 A 19910619 [Chinese].
76. Volosivets A.I., Adamov A.K. Study of the adjuvant properties of some substances in cholera vaccine immunization. Spetsificheskaya Profil Kholery, Tezisy Dokl. Vses Simp 1975, 41-43. [Russian].
77. Mu Y., Zhou L., Lu J., Li N., Li Y., Huang Q. Effect of different adjuvant for Newcastle Disease vaccine on humoral immunity in chicken. Chin Poult 2007, 2007-2019. [Chinese].
78. Zou Y., Yu S., Luo Y., Liu S., Li S. Development of the proplis-adjuvant pigeon inactivated avian paramyxovirus I (A/PMV-l) vaccine. Chin J Prevent Vet Med 2002, 2002-01. [Chinese].
79. Wang Z., Bi K. Study on canine distemper virus of mink and propolis vaccine. Xumu Yu Shouyi 2008, 40:79-81. [Chinese].
80. Chen K., Chao S., Liu P. Preliminary report on propolis inactivated vaccine of ducklings' virus hepatitis. J Anim Sci Vet Med 2000, 2000-2003. [Chinese].
81. Yu L, Li J, Huang Y, Li L. Polyprotein (VP2/VP4/VP3) gene of infectious bursal disease virus, its eukaryotic expression plasmid and use thereof as DNA vaccine. Faming Zhuanli Shenqing Gongkai Shuomingshu 2004; CN 1467293 A 20040114 [Chinese].
82. Chen K., He W., Lu H., Zhao K., Zhao C., Zeng F., et al. Comparison of different adjuvant inactive vaccines for hemagglutinating encephalomyelitis virus immunizing BALB/c mice. Zhongguo Xumu Shouyi 2009, 36:34-37. [Chinese].
83. Qiao J., Zhao M., Zhang X., Li Y., Li S., Liu W., et al. Preparation and comparison of three different adjuvant inactivated vaccines of Japanese encephalitis virus from swine. Huanan Nongye Daxue Xuebao 2011, 32:85-88. [Chinese].
84. Wang R., Xie Y., Shen Z., Miao X. Immunological enhancement and application of propolis. Zhongguo Xumu Shouyi 2007, 34:93-95. [Chinese].
85. Xu F., He Z. Recent advances in the mechanisms and application of immunoadjuvants. Zhongguo Shouyi Kexue 2007, 37:449-455. [Chinese].
86. Markonius M, inventor. Use of propolis components as an adjuvant. Sweden.
87. Song Y, Yang M, She X, Deng Y. Compound oil-in-water vaccine adjuvant, and its preparation method. Faming Zhuanli Shenqing 2010; CN 101703771 A 20100512 [Chinese].
88. Ouyang W, Zhang X, Li L. Compounded nanoemulsion vaccine adjuvant comprising propolis and Astragalus membranaceus polysaccharides, its preparation method and application. Faming Zhuanli Shenqing 2010; CN 101690809 A 20100407 [Chinese].
89. Gou S, Gou H, Wang C. Method for manufacturing human vaccine comprising propolis as adjuvant. Faming Zhuanli Shenqing Gongkai Shuomingshu 2005; CN 1683011 A 20051019 [Chinese].
90. Suzuki I., Tanaka H., Yajima H., Fukuda H., Sezaki H., Koga K., et al. Pharmaceutical research and development 1990, Hirokawa Publishing Co., Tokyo, pp. 227-41.
91. Lu C.P. Pathogenic Aeromonas hydrophila and the fish diseases caused by it. J Fish China 1992, 16:282-288. [Chinese].
92. Yang J, Su J, Peng X, Yin S, Fu L. Method for preparing propolis injection for preventing duck viral hepatitis type A. Faming Zhuanli Shenqing 2011; CN 102228481 A 20111102 [Chinese].
93. Schulthess J., Fourreau D., Darche S., Meresse B., Kasper L., Cerf-Bensussan N., et al. Mucosal immunity in Toxoplasma gondii infection. Parasite 2008, 15:389-395.
94. Yin G., Liu C., Liu J., Guan Z., Shi R., Zhang Y., et al. Cellular immune responses induced by intranasal immunization with soluble tachyzoites antigen of Toxoplasma gondii plus IFN-γ and propolis in mice. J Pathog Biol 2006, 2006-2011. [Chinese].
95. Liu C., Yin G., Zhao Y., Kong L. Effect of intranasal immunization with soluble tachyzoites antigen in combination with propolis and IFN-γ on antibody levels in mice. Zhongguo Gonggong Weisheng 2011, 27:1582-1583. [Chinese].
96. Liu C., Yin G., Zhao R., Kong L. Dynamics of intestinal lymphocyte in mice treated with complex vaccine against Toxoplasma gondii by intranasal immunization. Zhongguo Gonggong Weisheng 2012, 28:40-41. [Chinese].
97. Cowan M.M. Plants products as antimicrobial agent. Clin Microbiol Rev 1999, 12:564-582.
98. Bankova V.S., Castro S.L., Marcucci M.C., Propolis: recent advances in chemistry and plant origin. Apidologie 2000, 31:3-15.
99. Kujumgiev A., Tsvetkova I., Serkedjieva Y., Bankova V., Christov R., Popov S. Antibacterial, antifungal and antiviral activity of propolis of different geographic origin. J Ethnopharmacol 1999, 64:235-240.
100. Paulino N., Scremin F.M., Raichaski L.B., Marcucci M.C., Scremin A., Calixto J.B. Mechanisms involved in the relaxant action of the ethanolic extract of propolis in the guinea-pig trachea in vitro. J Pharm Pharmacol 2002, 54:1-9.
101. Zheng Z., Wang Y., Wang Q., Deng N., Liao M., Qu J., et al. Study on the immune enhancement of different immunoadjuvants used in the pentavalent vaccine for turbots. Fish Shellfish Immunol 2012, 32:391-395.
102. Sun Z., Wei K., Yan Z., Zhu X., Wang X., Wang H., et al. Effect of immunological enhancement of aloe polysaccharide on chickens immunized with Bordetella avium inactivated vaccine. Carbohydr Polym 2011, 86:684-690.
103. Fischer G., Cleff M.B., Dummer L.A., Paulino N., Paulino A.S., de Oliveira Vilela C., et al. Adjuvant effect of green propolis on humoral immune response of bovines immunized with bovine herpesvirus type 5. Vet Immunol Immunopathol 2007, 116:79-84.
104. Ma X., Guo Z., Shen Z., Wang J., Hu Y., Wang D. The immune enhancement of propolis adjuvant on inactivated porcine parvovirus vaccine in guinea pig. Cell Immunol 2011, 270:13-18.
105. Fischer G., Paulino N., Marcucci M.C., Siedler B.S., Munhoz L.S., Finger P.F., et al. Green propolis phenolic compounds act as vaccine adjuvants, improving humoral and cellular responses in mice inoculated with inactivated vaccines. Mem Inst Oswaldo Cruz 2010, 105:908-913.
106. Namiki H, Matsuka M, Nakamura J, Adachi S, Watanabe G, Okazaki M, inventor. Propolis extract and method for extracting the same. WO 2005/094853 A1.
107. Jiang Z.G., Wang N., Fang W.H., Sun J.H., Li H.M. Serological and virulence factors analysis of Escherichia coli isolates causing post-weaning diarrhea in intensive pig farms. J Zhejiang Univ (Agric Life Sci) 2006, 32:520-526. [Chinese].
108. Marquardt R.R., Baidoo S.K., Kim J.W. Therapeutic antibodies in pig diets. The 18th Western Nutrition Conference 1997, 81-88.
109. Reynaud C.A., Dahan A., Anquez V., Weill J.C. Somatic hyperconversion diversifies the single VH gene of the chicken with a high incidence in the D region. Cell 1989, 59:171-183.
110. Sun J.L., Jiang Z., Hu S. Effect of four adjuvants on immune response to F4 fimbriae in chickens. Vet Immunol Immunopathol 2008, 121:107-112.
111. Myers L.L., Newman F.S., Wilson R.A., Catlin J.E. Passive immunization of calves against experimentally induced enteric colibacillosis by vaccination of dams. Am J Vet Res 1973, 34:29-33.
112. Yu H., Ren Y. Preparation and detection of propolis adjuvant inactivated vaccine against calf pathogenic Escherichia coli. Xumu Yu Shouyi 2009, 41:68-71. [Chinese].
113. Hao G., Pan X., Yao J., Xu Y., Yin W., Shen J. Selection and application of immunization adjuvant in four-strain inactivated bacterial vaccines in soft shelled turtle. Dalian Shuichan Xueyuan Xuebao 2010, 25:19-23. [Chinese].
114. Bureau of Fisheries MoA, People's Republic of China. China fisheries yearbook; 2010 [Chinese].
115. Wang Y.G., Zhang Z., Qin L., Shi C.Y., Chen J.J., Yang S.L., et al. The main diseases of cultured turbot (Scophthalmus maximus) and their prevention and treatment. Mar Fish Res 2004, 25:61-88. [Chinese].
116. Chapel H.M., August P.J. Report of nine cases of accidental injury to man with Freund's complete adjuvant. Clin Exp Immunol 1976, 24:538-541.
117. Chillingworth N.L., Donaldson L.F. Characterisation of a Freund's complete adjuvant-induced model of chronic arthritis in mice. J Neurosci Methods 2003, 128:45-52.
118. Ahmad T.A., Haroun M., Hussein A.A., El Ashry E.S.H., El-Sayed L.H. Development of a new trend conjugate vaccine for the prevention of Klebsiella pneumoniae. Infect Dis Rep 2012, 4:128-133.
119. Ahmad T.A., El-Sayed L.H., Haroun M., Hussein A.A., El Ashry el S.H. Development of immunization trials against Klebsiella pneumoniae. Vaccine 2012, 30:2411-2420.
120. Ahmad TA. Construction and evaluation of a conjugate vaccine for the prevention of septicemia. PhD. Alexandria: Alexandria University; 2012.
121. Nassar S.A., Mohamed A.H., Soufy H., Nasr S.M., Mahran KM Immunostimulant effect of Egyptian propolis in rabbits. Sci World J 2012, 901516.
122. Zhang B., Wang D., Kong X., Hu Y. Studies on immunoenhancement of propolis flavone. Yangzhou Daxue Xuebao, Nongye Yu Shengming Kexueban 2006, 27:20-22. [Chinese].
123. Piatti R.M., Ikuno A.A., Cunha E.S., D'ambros R., Gregori F., Soares R.M., et al. Characterization of Aujesky's disease virus isolated from south Brazil by RFLP analysis. Braz J Microb 2001, 32:144-146.
124. Fischer G., Conceicao F.R., Leite F.P.L., Dummer L.A., Vargas G.D., Huebner S.O., et al. Immunomodulation produced by a green propolis extract on humoral and cellular responses of mice immunized with SuHV-1. Vaccine 2007, 27:1250-1256.
125. Nelson C.B., Pomeroy B.S., Schrall K., Park W.E., Lindeman R.J. An outbreak of conjunctivitis due to Newcastle disease virus (NDV) occurring in poultry workers. Am J Public Health 1952, 42:672-678.
126. Chai J., Pang X., Liu J., Shen Z. Immune mechanisms of ND nanometer propolis inactivated vaccine of chickens. Zhongguo Shouyi Xuebao 2010, 30:1151-1155. [Chinese].
127. Yuan J., Liu J., Hu Y., Fan Y., Wang D., Guo L., et al. The immunological activity of propolis flavonoids liposome on the immune response against ND vaccine. Int J Biol Macromol 2012, 51:400-405.
128. Parke C.R., Burgess G.W. An economic assessment of porcine parvovirus vaccination. Aust Vet J 1993, 70:177-180.
129. Qiao Y, Sun J. Avian vaccine slow release agent, its preparation and inoculation method. Faming Zhuanli Shenqing 2009; CN 101376023 A 20090304 [Chinese].
130. Wu Y, Jin Z, Gao S. Pharmaceutical composition for improving poultry immunity and enhancing immunization of vaccine, and preparation method thereof. Faming Zhuanli Shenqing 2009; CN 101474246 A 20090708 [Chinese].
131. Hu Y.L. Progress in the study of immunopharmacology of Chinese herbal medicine. Chin J Immunol 1997, 3:96-98. [Chinese].
132. Exploitation and application of new-type preparation of Chinese herbal medicine 2000, People Sanitary Press, Beijing.
133. Liu J.X., Wang C.Y., Bai Y.M., Fang Y.P. Influence of Astragalus and other nine natural medicines on Newcastle disease antibody titers (ND-HI), coefficient of the immune organs and gains of chicks. Chin J Vet Sci Technol 1998, 12:30-32. [Chinese].
134. Kong X.F., Hu Y.L., Rui R., Wang D., Li X. Effect of Chinese herbal medicinal ingredients on peripheral lymphocyte proliferation and serum antibody titer after vaccination in chicken. Int Immunopharmacol 2004, 4:975-982.
135. Wang D., Hu Y., Sun J., Kong X., Zhang B., Liu J. Comparative study on adjuvanticity of compound Chinese herbal medicinal ingredients. Vaccine 2005, 23:3704-3708.
136. Sun J.L., Hu Y.L., Wang D.Y., Zhang B.K., Liu J.G. Immunologic enhancement of compound Chinese herbal medicinal ingredients and their efficacy comparison with compound Chinese herbal medicines. Vaccine 2005, 24:2343-2348.
137. Wang D., Hu Y., Sun J., Zhang B., Liu J. Effect of Chinese herbal medicinal ingredient prescription on peripheral T lymphocyte transformation and serum antibody titer of chickens inoculated with ND vaccine. Zhongguo Shouyi Xuebao 2006, 26:194-196. [Chinese].
138. Yang L., Hu Y., Xue J., Wang F., Wang D., Kong X., et al. Compound Chinese herbal medicinal ingredients can enhance immune response and efficacy of RHD vaccine in rabbit. Vaccine 2008, 26:4451-4455.
139. Yang L., Hu Y., Xue J., Wang F., Wang D., Xu W. Effects of compound Chinese medicinal ingredients on peripheral blood lymphocyte proliferation, mRNA expression of IFN-γ and IL-10 and immunological effect on rabbit hemorrhagic disease (RHD) vaccine. Zhongguo Nongye Kexue (Beijing, China) 2008, 41:3809-3815. [Chinese].
140. Fan Y., Hu Y., Wang D., Guo Z., Zhao X., Guo L., et al. Epimedium polysaccharide and propolis flavone can synergistically stimulate lymphocyte proliferation in vitro and enhance the immune responses to ND vaccine in chickens. Int J Biol Macromol 2010, 47:87-92.
141. Wei G. Effect of complex polysaccharide on immune efficacy of Riemerella anatipestifer vaccine. Xumu Yu Shouyi 2010, 42:64-66. [Chinese].
142. Fan Y., Wang D., Hu Y., Liu J., Han G., Zhao X., et al. Liposome and epimedium polysaccharide-propolis flavone can synergistically enhance immune effect of vaccine. Int J Biol Macromol 2012, 50:125-130.